Development Team

The Development Team at Akero Therapeutics is responsible for advancing the company's lead product candidate, efruxifermin (EFX), through the clinical development process. This includes overseeing the drug substance process development, managing clinical trial operations, developing medical devices related to the treatment, and ensuring optimal packaging and usability. The team, led by experienced leaders in drug development and engineering, focuses on translating research breakthroughs into effective, approved therapies for non-alcoholic steatohepatitis (NASH).